Other and unspecified glaucoma

H7_GLAUCNAS

glaucoma: Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H40.8, H40.9 Hospital discharge: ICD-9 — 3656X\|3656C\|365[8-9] Hospital discharge: ICD-8 — 3752\|3759 Hospital discharge: excluded ICD-8 — 37597 Cause of death: ICD-10 — H40.8, H40.9 Cause of death: ICD-9 — 3656X\|3656C\|365[8-9] Cause of death: ICD-8 — 3752\|3759 Cause of death: excluded ICD-8 — 37597 2 out of 7 registries used, show all original rules.	2592
4. Check minimum number of events None	2592
5. Include endpoints None	2592
6. Filter based on genotype QC (FinnGen only)	2592

Control definitions (FinnGen only)

Control exclude: H7_GLAUCOMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	H7_GLAUCNAS
CONTROL_EXCLUDE	H7_GLAUCOMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H40[8-9]
HD_ICD_9	3656X\|3656C\|365[8-9]
HD_ICD_8	3752\|3759
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	37597
COD_MAINONLY
COD_ICD_10	H40[8-9]
COD_ICD_9	3656X\|3656C\|365[8-9]
COD_ICD_8	3752\|3759
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	37597
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified glaucoma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	27050	16252	10529
Only index persons	21210	13148	8062
Unadjusted period prevalence (%)
Whole population	0.40	0.47	0.29
Only index persons	0.42	0.48	0.31
Median age at first event (years)
Whole population	73.83	76.31	70.15
Only index persons	74.25	76.75	70.16

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2592	1423	1169
Unadjusted period prevalence (%)	0.50	0.49	0.52
Median age at first event (years)	70.83	71.31	70.25

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2285: Matched controls
22860

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H40.0

ICD-10 Finland

Glaucoma suspect

225.1

323.0

703

S01ED51

ATC

timolol, combinations; ophthalmic

117.7

323.0

1502

365

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

335.2

323.0

614

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

1242.2

323.0

409

114

Kela drug reimbursment

Glaucoma

252.9

323.0

1890

420

S01EC04

ATC

brinzolamide; ophthalmic

123.5

323.0

733

S01EC03

ATC

dorzolamide; ophthalmic

105.0

323.0

355

S01EE03

ATC

bimatoprost; ophthalmic

77.7

323.0

388

H40.9

ICD-10 Finland

Glaucoma, unspecified

4872.0

323.0

1786

S01EX03

ATC

83.4

323.0

518

S01EC01

ATC

acetazolamide; systemic

51.1

323.0

430

103

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

665.4

323.0

909

S01ED01

ATC

timolol; ophthalmic

65.9

323.0

822

193

S01EE01

ATC

latanoprost; ophthalmic

91.4

323.0

1232

288

XCK00

NOMESCO Finland

Perimetry

28.8

323.0

761

389

S01EE04

ATC

travoprost; ophthalmic

69.6

323.0

417

S01EE05

ATC

tafluprost; ophthalmic

51.8

323.0

452

108

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

4315.4

323.0

375

H40.8

ICD-10 Finland

Other glaucoma

2079.9

323.0

340

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2682.2

264.7

251

XCH00

NOMESCO Finland

Eye pressure measurement

16.2

227.7

384

282

H40.11

ICD-10 Finland

Low pressure glaucoma

281.2

203.5

205

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

32.1

200.3

268

XCW99

NOMESCO Finland

Other investigative procedure of eye

5.9

196.1

626

1362

S01ED02

ATC

betaxolol; ophthalmic

106.7

196.0

213

S01EC54

ATC

brinzolamide, combinations; ophthalmic

126.7

184.4

197

Z96.1

ICD-10 Finland

Presence of intraocular lens

4.7

184.1

769

2239

H40

ICD-10 Finland

Glaucoma

58.9

181.6

214

CHD00

NOMESCO Finland

Laser trabeculoplasty

597.8

170.6

167

XCK10

NOMESCO Finland

Photography of fundus of eye

5.3

157.8

546

1270

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.4

153.2

658

1914

S01EB01

ATC

pilocarpine; ophthalmic

107.5

147.2

160

WX140

NOMESCO Finland

Parabulbar anesthesy

9.0

145.0

325

411

CHC05

NOMESCO Finland

Iridotomy

70.5

143.1

164

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

5.7

141.1

454

958

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

36.5

140.6

182

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

3.0

136.2

1341

7300

37520

ICD-8 Finland

Glaucoma, Secondary

+∞

134.7

128

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

+∞

126.2

120

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

1264.7

124.2

120

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

+∞

122.0

116

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.8

120.4

1273

7027

S01EA03

ATC

apraclonidine; ophthalmic

32.5

118.9

158

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

+∞

111.4

106

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.7

106.6

1199

6679

XCH05

NOMESCO Finland

Eye pressure longterm registration

348.8

100.9

101

H25.1

ICD-10 Finland

Senile nuclear cataract

2.6

99.3

1074

5769

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

211.2

98.3

101

S01EA02

ATC

dipivefrine; ophthalmic

503.9

98.2

3651A

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]

+∞

93.4

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

7.9

93.1

224

310

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

902.6

89.3

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

+∞

74.4

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

12.4

72.5

134

114

H20.1

ICD-10 Finland

Chronic iridocyclitis

18.9

70.8

110

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

107.7

67.3

CHD99

NOMESCO Finland

Other filtering operation

+∞

67.0

3656X

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]

+∞

67.0

ZXE00

NOMESCO Finland

One hour or less

2.2

66.7

1030

6206

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

+∞

65.9

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

+∞

63.8

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.1

63.8

393

1419

ZXA10

NOMESCO Finland

Bilateral

2.5

62.3

621

3004

H26.4

ICD-10 Finland

After-cataract

2.9

60.3

422

1658

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

19.9

57.8

CHD35

NOMESCO Finland

Laser goniopuncture

+∞

57.5

37510

ICD-8 Finland

Glaucoma, Chronicum simplex

+∞

55.4

F93

ICPC

Glaucoma

99.2

53.0

ZXA00

NOMESCO Finland

Right side

2.1

49.9

805

4774

CS494

NOMESCO Finland

Other visual field testing

11.2

48.9

H34.8

ICD-10 Finland

Other retinal vascular occlusions

6.7

47.6

126

198

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

4.9

47.5

163

352

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

6.6

45.6

122

195

3708

FHL

Trabeculectomy or equivalent

+∞

44.9

ZXA05

NOMESCO Finland

Left side

2.0

44.6

754

4507

Z3231

NOMESCO Finland

Registered nurse

2.0

44.3

734

4351

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

44.2

299

1131

WX002

NOMESCO Finland

Sedation and analgesia

2.2

44.2

564

2996

H40.1

ICD-10 Finland

Primary open-angle glaucoma

156.4

43.9

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

+∞

41.8

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.6

41.4

200

593

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

40.7

917

6044

S01BC03

ATC

diclofenac; ophthalmic

5.4

38.6

120

232

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

5.1

37.8

123

250

H04.10

ICD-10 Finland

Dry eye syndrome

2.7

36.8

272

1081

H40.12

ICD-10 Finland

Pigmentary glaucoma

362.8

36.1

37597

ICD-8 Finland

Glaucoma, Suspicio glaucomatis

+∞

35.5

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.2

35.1

201

677

3656C

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA NEOVASCULARE]

+∞

34.5

CFW99

NOMESCO Finland

Other operation on conjunctiva

177.6

33.8

CS2P4

NOMESCO Finland

Optic nerve head imaging

94.0

33.8

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

+∞

33.4

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

7.4

33.4

113

S01FA01

ATC

atropine; ophthalmic

17.4

32.4

CKC12

NOMESCO Finland

Photocoagulation of retina

4.1

32.2

130

330

H16.0

ICD-10 Finland

Corneal ulcer

3.8

32.2

141

385

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.8

31.6

108

232

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

31.4

927

6495

3659X

ICD-9 Finland

Glaucoma, Unspecified glaucoma

+∞

31.3

3711

FHL

Cyclodiateria or cryocoagulation

+∞

31.3

H26.2

ICD-10 Finland

Complicated cataract

7.8

30.8

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

306.3

29.9

36402

ICD-8 Finland

Iritis, Iridocyclitis, uveitis chronica

57.5

29.2

CKD40

NOMESCO Finland

Endophotocoagulation of retina

7.8

28.8

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.1

28.7

361

1863

SPAT1009

SPAT

Measurement of intraocular pressure

7.6

28.7

37598

ICD-8 Finland

Glaucoma, Aliud definitum

+∞

28.2

H33.0

ICD-10 Finland

Retinal detachment with retinal break

4.3

28.1

107

257

H43.1

ICD-10 Finland

Vitreous haemorrhage

4.9

27.6

193

3719

FHL

Other measure in this category

+∞

27.1

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

+∞

27.1

ZXC20

NOMESCO Finland

Use of chemical agents

4.7

26.5

206

WX110

NOMESCO Finland

Local anesthesy

1.6

25.9

1329

10608

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

6.1

25.8

119

S01FA04

ATC

cyclopentolate; ophthalmic

7.9

25.7

37872

ICD-8 Finland

Other diseases of eye, Aphakia artefacta, acquisita

27.9

24.5

XCW10

NOMESCO Finland

Assessment of vision

15.8

24.1

ZXD05

NOMESCO Finland

Urgent procedure

1.7

23.8

714

4926

Z2221

NOMESCO Finland

Medical doctor

1.7

23.3

614

4078

TCG20

NOMESCO Finland

Laser suture lysis in cornea or sclera

+∞

22.9

H18.1

ICD-10 Finland

Bullous keratopathy

24.1

22.2

CKC20

NOMESCO Finland

Cryopexy of undetached retina

21.6

22.1

3641A

ICD-9 Finland

Disorders of iris and ciliary body, Chronic iridocyclitis

52.5

22.1

H44.5

ICD-10 Finland

Degenerated conditions of globe

63.1

21.9

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

11.0

21.6

H57.1

ICD-10 Finland

Ocular pain

4.1

21.5

218

H27.0

ICD-10 Finland

Aphakia

18.0

20.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

20.8

1472

12356

R4110

NOMESCO Finland

Physiotherapy

1.6

20.5

610

4164

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

20.2

20.4

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

14.4

20.3

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.6

20.2

159

WX144

NOMESCO Finland

Subconjunctival anesthesy

5.2

20.0

125

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.2

19.9

218

1052

H21.0

ICD-10 Finland

Hyphaema

22.7

19.1

3656F

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]

+∞

18.8

CKD15

NOMESCO Finland

Injection of vitreous substitute

13.5

18.7

H54.4

ICD-10 Finland

Blindness, monocular

15.2

18.4

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

3.0

18.4

106

359

A10AA02

ATC

3.1

18.3

105

355

37599

ICD-8 Finland

Glaucoma, Unspecified

+∞

17.7

3793A

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]

37.0

17.6

CKD20

NOMESCO Finland

Removal of vitreous body substitute

13.2

17.4

TCG10

NOMESCO Finland

Removal of sutures from cornea

10.1

17.4

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

31.7

17.0

J01DB01

ATC

cefalexin; oral

1.5

17.0

1676

14749

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.1

16.8

308

H40.29

ICD-10 Finland

Other [primary] glaucoma with closed ventricular angle

+∞

16.7

A10AA01

ATC

3.8

16.3

190

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.6

16.2

117

458

S01BC05

ATC

ketorolac; ophthalmic

2.3

16.2

150

670

H3603, E103

ICD-10 Finland

7.3

16.0

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

21.1

16.0

H27.1

ICD-10 Finland

Dislocation of lens

10.8

16.0

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.8

15.8

CFB00

NOMESCO Finland

Suture of conjunctiva

33.6

15.7

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

15.8

15.7

CKC15

NOMESCO Finland

Panretinal photocoagulation

6.1

15.6

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.6

15.6

113

444

CHC00

NOMESCO Finland

Iridotomy

161.0

15.5

A10AE04

ATC

insulin glargine; parenteral

1.9

15.3

230

1259

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.0

15.3

311

WX142

NOMESCO Finland

Sub-tenon anesthesy

9.8

15.2

H20.8

ICD-10 Finland

Other iridocyclitis

13.1

15.2

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

8.1

15.0

3626

FHL

Extracapsular cataract surgery and implantation of an artificial lens

3.3

15.0

226

3643

FHL

Vitrectomy through pars Plana

25.2

14.7

CHD10

NOMESCO Finland

Trabeculectomy

+∞

14.6

S01EX

ATC

Other antiglaucoma preparations

+∞

14.6

37512

ICD-8 Finland

Glaucoma, Chronicum capsulare

+∞

14.6

TCA15

NOMESCO Finland

Retrobulbar therapeutic injection into orbit

150.9

14.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

14.4

369

2392

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

7.2

14.3

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.3

14.1

124

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

8.0

14.0

N02BE01

ATC

paracetamol; systemic, rectal

1.5

14.0

1860

16955

CFD10

NOMESCO Finland

Repair of conjunctiva

30.2

13.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

13.8

252

1474

37404

ICD-8 Finland

Cataract, Secundaria

53.7

13.8

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

13.6

180

942

CG2T4

NOMESCO Finland

Topography assessment of cornea

7.2

13.5

A28

ICPC

Limited function/disability NOS

1.6

13.5

447

3090

H26.02

ICD-10 Finland

Presenil cataract

3.4

13.5

196

3663A

ICD-9 Finland

Cataract secondary to ocular disorders

12.9

13.4

F38

ICPC

Eye, Other laboratory test NEC

12.9

13.4

37403

ICD-8 Finland

Cataract, Complicata

25.9

13.4

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

8.1

13.3

F43

ICPC

Eye, Other diagnostic procedure

4.2

13.2

118

ZXD20

NOMESCO Finland

Day surgery

1.7

13.2

273

1665

T89

ICPC

Diabetes insulin dependent

3.0

13.2

260

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

7.1

13.0

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

4.1

12.8

122

S01EX05

ATC

netarsudil; ophthalmic

+∞

12.5

Q15.0

ICD-10 Finland

Congenital glaucoma

+∞

12.5

L28

ICPC

Limited function/disability (L)

1.5

12.5

424

2942

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.6

12.3

351

R53

ICD-10 Finland

Malaise and fatigue

1.5

12.2

477

3413

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

12.1

134

652

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

4.8

12.1

CKD60

NOMESCO Finland

Anterior vitrectomy

4.7

12.0

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

10.1

12.0

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

7.6

11.9

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.1

11.8

112

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

11.8

527

3879

A98

ICPC

Health maint/preventive medicine

1.5

11.6

1934

17952

Z90.0

ICD-10 Finland

Acquired absence of part of head and neck

19.0

11.6

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

+∞

11.5

37511

ICD-8 Finland

Glaucoma, Chronicum irritativum sive congestivum

+∞

11.5

3652A

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[AKUUTTI AHDASKULMAGLAUKOOMA]

+∞

11.5

CHC03

NOMESCO Finland

Laser iridoplasty

120.6

11.4

CKC10

NOMESCO Finland

Local photocoagulation of retina

3.1

11.4

194

CD2S4

NOMESCO Finland

Photography of eye

9.6

11.2

H25.0

ICD-10 Finland

Senile incipient cataract

1.9

11.0

169

934

H02AB06

ATC

prednisolone; systemic

1.4

11.0

982

8161

F99

ICPC

Eye/adnexa disease other

6.3

10.9

R05

ICD-10 Finland

Cough

1.5

10.7

380

2655

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

9.6

10.7

CHB99

NOMESCO Finland

Other operation on anterior chamber and anterior chamber angle

60.3

10.6

WX402

NOMESCO Finland

General anaesthesia

1.6

10.6

278

1803

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

3.7

10.6

119

H01.0

ICD-10 Finland

Blepharitis

2.3

10.6

448

S01BA09

ATC

clobetasone; ophthalmic

14.3

10.5

H40.21

ICD-10 Finland

Intermittent glaucoma with closed ventricular angle

+∞

10.4

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

+∞

10.4

3652B

ICD-9 Finland

Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]

+∞

10.4

S01FA06

ATC

tropicamide; ophthalmic

32.7

10.3

-1

NOMESCO Finland

1.4

10.3

532

4013

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.8

10.3

231

M79.6

ICD-10 Finland

Pain in limb

1.4

10.2

684

5405

H54.0

ICD-10 Finland

Blindness, binocular

13.2

10.2

Z3226

NOMESCO Finland

Physiotherapist

1.5

10.1

394

2809

S01AD03

ATC

aciclovir; ophthalmic

2.3

10.0

421

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

10.0

499

3740

R50.9

ICD-10 Finland

Fever, unspecified

1.6

9.9

272

1787

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

20.1

9.8

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

3.9

9.8

102

S01FA02

ATC

scopolamine; ophthalmic

4.6

9.7

C09CA01

ATC

losartan; oral

1.4

9.7

542

4141

SPAT1262

SPAT

Handing over of treatment supplies

1.5

9.6

385

2759

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

3.3

9.5

142

F29

ICPC

Eye symptom/complaint other

1.8

9.4

156

885

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

7.6

9.4

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.7

9.4

106

3702

FHL

Trabeculotomy

+∞

9.4

3623C

ICD-9 Finland

Other retinal disorders, Retinal vascular occlusion[OCCLUSIO VENAE CENTRALIS RETINAE]

+∞

9.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

9.4

459

3419

3793C

ICD-9 Finland

Other disorders of eye, Aphakia and other disorders of lens[PSEUDOPHAKIA]

6.9

9.3

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

9.3

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

4.7

9.2

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

7.7

9.1

E0000UV

ATC

1.3

9.1

741

6018

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.6

9.0

CWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in eye and adjacent structures

36.8

9.0

Z94.7

ICD-10 Finland

Corneal transplant status

7.1

9.0

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

2.0

9.0

107

539

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.9

9.0

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.2

8.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

8.9

354

2530

A02BC02

ATC

pantoprazole; systemic

1.3

8.9

1357

12050

H16.9

ICD-10 Finland

Keratitis, unspecified

3.5

8.8

112

Z2446

NOMESCO Finland

Social worker

1.9

8.8

130

712

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

9.5

8.8

-44

ICPC

Preventive immunization/medic

1.7

8.7

189

1166

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

8.7

592

4665

3792A

ICD-9 Finland

Other disorders of eye, Disorders of vitreous body

50.2

8.7

S18

ICPC

Laceration/cut

1.3

8.6

849

7085

C08CA01

ATC

amlodipine; oral

1.3

8.6

831

6915

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.3

8.5

CDC40

NOMESCO Finland

Evisceration of eye with insertion of prosthesis

90.4

8.4

3649

FHL

Other measure in this category

90.4

8.4

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

8.4

464

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

8.4

592

4692

3656B

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUKOMASYKLIITTINEN KRIISI,SYNDR POSSNER-SCHOSSMAN]

+∞

8.3

37500

ICD-8 Finland

Glaucoma, Primary, acute

+∞

8.3

36401

ICD-8 Finland

Iritis, Iridocyclitis glaucomatosa. Syndroma Posner-Schlossman, heterochromia iridis

+∞

8.3

H18.8

ICD-10 Finland

Other specified disorders of cornea

5.5

8.3

CG2S4

NOMESCO Finland

Photography of cornea

7.1

8.2

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

7.1

8.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

8.2

947

8056

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

8.2

292

2038

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

8.1

539

4223

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

8.1

792

6585

CDC00

NOMESCO Finland

Enucleation of eye

33.5

8.1

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

17.2

8.1

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.6

8.1

226

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

8.0

595

4743

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

8.0

429

3245

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.9

686

5596

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.5

7.9

252

3744

FHL

Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)

13.1

7.9

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

7.8

135

778

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

7.8

104

547

3661A

ICD-9 Finland

Cataract, Senile cataract

2.7

7.8

186

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.7

7.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.9

7.8

104

549

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

7.8

608

4885

3690A

ICD-9 Finland

Blindness and low vision, Profound impairment, both eyes

45.1

7.7

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

45.1

7.7

UJF32

NOMESCO Finland

Coloscopy

1.3

7.7

547

4332

H25.8

ICD-10 Finland

Other senile cataract

1.5

7.6

299

2127

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

7.6

580

4638

CGF35

NOMESCO Finland

Repair of cornea using graft

25.1

7.6

A10AE05

ATC

insulin detemir; parenteral

1.9

7.6

110

599

R42

ICD-10 Finland

Dizziness and giddiness

1.4

7.5

493

3849

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.3

7.5

293

H31.4

ICD-10 Finland

Choroidal detachment

80.3

7.4

H44.4

ICD-10 Finland

Hypotony of eye

80.3

7.4

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

80.3

7.4

3102

FHL

Enucleation

80.3

7.4

M54.5

ICD-10 Finland

Low back pain

1.3

7.4

569

4556

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

6.0

7.4

37513

ICD-8 Finland

Glaucoma, Chronicum pigmentosum

+∞

7.3

3656E

ICD-9 Finland

Glaucoma associated with other ocular disorders[GLAUCOMA POSTTRAUMATICUM]

+∞

7.3

7432A

ICD-9 Finland

Congenital anomalies of eye, Buphthalmos[GLAUCOMA CONGENITUM]

+∞

7.3

R3120

NOMESCO Finland

Training in mobility skills

10.9

7.3

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

7.3

424

3246

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

7.3

293

2097

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

7.3

173

1097

36409

ICD-8 Finland

Iritis, Unspecified

15.8

7.2

N03AX16

ATC

pregabalin; oral

1.4

7.2

446

3452

37700

ICD-8 Finland

Other diseases of retina and optic nerve, Haemorrhagia corporis vitrei

30.1

7.1

S01AX11

ATC

[U] ofloxacin; ophthalmic

1.9

7.1

517

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

7.0

222

1509

C03CA01

ATC

furosemide; systemic

1.3

7.0

801

6762

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

7.0

401

3062

XCD20

NOMESCO Finland

Photoangiography of eye

2.5

7.0

201

SPAT1014

SPAT

Treatment of eyes

2.4

7.0

230

H33.5

ICD-10 Finland

Other retinal detachments

4.5

7.0

AA1AD

NOMESCO Finland

CT of head and brain

1.3

6.9

537

4296

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

6.9

226

1547

S01BC01

ATC

indometacin; ophthalmic

13.8

6.9

N30.0

ICD-10 Finland

Acute cystitis

1.4

6.9

308

2250

C08CA13

ATC

lercanidipine; oral

1.4

6.9

309

2257

F28

ICPC

Limited function/disability (F)

4.8

6.8

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

6.8

218

1486

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

6.8

328

2429

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

9.3

6.8

J01FF01

ATC

clindamycin; systemic

1.3

6.8

494

3915

H44.1

ICD-10 Finland

Other endophthalmitis

16.7

6.7

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.0

6.7

411

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

6.7

212

1441

H3603, E113

ICD-10 Finland

3.5

6.7

S97

ICPC

Chronic ulcer skin

1.7

6.7

128

764

3747

FHL

Combined ablation and vitreous surgery with coagulation

22.6

6.7

H04AA01

ATC

glucagon; nasal, parenteral

3.0

6.7

117

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

6.7

439

3424

Z71.8

ICD-10 Finland

Other specified counselling

1.4

6.7

396

3042

L20.0

ICD-10 Finland

Besnier prurigo

2.1

6.6

329

H53.4

ICD-10 Finland

Visual field defects

2.5

6.6

187

H26.3

ICD-10 Finland

Drug-induced cataract

5.2

6.6

J05AB01

ATC

aciclovir; systemic

1.4

6.6

374

2845

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

6.6

113

651

H34.1

ICD-10 Finland

Central retinal artery occlusion

4.6

6.6

J01MA02

ATC

ciprofloxacin; systemic

1.3

6.6

809

6887

JN4BD

NOMESCO Finland

Extensive body CT

1.5

6.5

236

1651

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

10.0

6.5

H18.4

ICD-10 Finland

Corneal degeneration

6.9

6.5

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

6.5

198

1334

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

6.5

195

1311

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

6.5

174

1139

F01

ICPC

Eye pain

2.5

6.5

202

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

5.3

6.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

6.4

538

-69

ICPC

Other reason for encounter NEC

1.9

6.4

435

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

6.4

142

884

3745

FHL

Hard membrane girding, cerclage with coagulation

14.3

6.4

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.7

6.4

120

711

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

4.1

6.4

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

2.9

6.4

121

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

8.2

6.3

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

6.3

157

1010

3654A

ICD-9 Finland

Glaucoma associated with congenital anomalies, dystrophies and systemic syndromes

+∞

6.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

6.2

361

2758

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

3.2

6.1

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

4.7

6.1

R60.0

ICD-10 Finland

Localized oedema

1.4

6.1

240

1711

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

6.1

131

812

J01CA04

ATC

amoxicillin; systemic

1.3

6.1

1522

14023

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

6.1

366

H10.5

ICD-10 Finland

Blepharoconjunctivitis

2.9

6.1

114

37600

ICD-8 Finland

Detachment of retina, Primaria

10.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3030467) Casts [#/volume] in Urine by Automated count

1048

6271

2.13

71.83

4.0

3.4

e6/l

0.6

0.5

0.22

806

4810

(3002582) Erythrocytes [#/volume] in Urine

1115

6837

2.11

71.57

4.1

3.5

e6/l

48.7

80.9

1.22

874

5296

(36304419) Bacteria [Presence] in Urine

1006

6024

2.09

67.89

4.0

3.3

—

(3018095) Leukocytes [#/volume] in Urine

1200

7785

2.01

63.81

4.9

3.9

e6/l

92.6

151.8

2.06

900

5653

(3021589) Normoblasts [#/volume] in Blood

1268

8598

1.93

57.18

12.7

10.2

e9/l

0.0

0.17

1035

6912

(3002385) Erythrocyte distribution width [Ratio]

1934

15417

2.00

50.27

27.5

21.2

14.0

13.9

1.04

1886

15023

(3018418) pH of Serum or Plasma

1027

6819

1.84

46.55

4.8

3.9

7.4

0.48

257

1226

(3000850) Epithelial cells [#/volume] in Urine

784

4820

1.90

45.04

3.2

2.7

e6/l

5.7

5.4

0.14

693

4228

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

642

3692

1.98

45.02

3.4

3.0

e6/l

2.3

2.6

0.44

346

2056

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

458

2347

2.16

43.82

4.2

3.7

—

(3026782) Osmolality of Urine

749

4607

1.88

42.54

3.3

2.9

mosm/kgh2o

527.5

543.5

1.32

651

3897

(42870588) Differential panel, method unspecified - Blood

1012

7052

1.71

36.39

6.0

5.6

—

(3033658) Prothrombin time (PT) actual/Normal

817

5445

1.73

34.02

4.7

3.9

84.2

85.1

0.47

796

5302

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

634

3932

1.81

33.85

3.3

2.9

e6/l

5.8

1.3

0.47

338

2290

(3031040) Bacteria [#/volume] in Urine by Automated count

1737

14291

1.65

30.34

6.3

5.3

e6/l

1364.0

3135.6

0.62

236

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1904

16103

1.69

29.23

8.5

7.6

u/l

80.8

81.1

0.12

1779

15020

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2085

18186

1.75

27.27

22.4

16.4

ml/min/173m2

73.2

72.6

0.60

1783

15085

(40761536) Microorganisms panel - Urine sediment

316

1670

2.02

27.02

5.0

4.5

—

(3022096) Basophils/100 leukocytes in Blood

1193

9123

1.57

26.99

7.2

5.8

0.6

0.7

0.31

1113

8420

(3007853) Bacteria identified in Skin by Aerobe culture

426

2495

1.85

26.76

2.1

1.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

1238

9581

1.56

26.34

7.3

6.0

24.2

26.2

7.54

1150

8810

(3044889) 12 lead EKG panel

1705

14197

1.59

26.12

4.6

4.3

—

(3023368) Bacteria identified in Blood by Culture

929

6746

1.59

26.05

5.3

4.3

—

(40758558) Short blood count panel - Blood

744

5125

1.63

25.96

7.5

6.7

—

(3006504) Eosinophils/100 leukocytes in Blood

1211

9365

1.55

25.59

7.2

5.8

2.7

2.8

0.30

1129

8637

(3019069) Monocytes/100 leukocytes in Blood

1215

9403

1.55

25.58

7.4

6.1

8.9

0.01

1136

8696

(3009542) Hematocrit [Volume Fraction] of Blood

1958

16906

1.65

25.29

25.2

18.9

37.8

38.3

1.10

1304

10511

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2202

19630

1.81

25.20

22.9

17.3

mg/l

28.6

26.7

1.69

1897

16073

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1318

10417

1.54

25.00

7.0

5.8

mmol/l

1.2

0.80

1219

9321

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

506

3182

1.73

24.81

2.8

2.5

20.8

21.7

0.72

441

2661

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1428

11500

1.54

24.74

7.4

6.6

mmol/l

1.2

0.26

1146

9674

(3013826) Glucose [Moles/volume] in Serum or Plasma

1553

12761

1.54

24.34

5.8

4.7

mmol/l

6.9

0.39

1494

12011

(3018010) Neutrophils/100 leukocytes in Blood

1206

9411

1.53

23.85

7.2

5.8

60.8

58.6

7.49

1127

8706

(3032080) INR in Blood by Coagulation assay

1217

9569

1.51

22.88

11.8

10.9

inr

1.3

1.4

0.07

459

2494

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

332

1884

1.87

22.83

4.1

3.5

mmol/l

1.2

0.25

298

1620

(3012095) Magnesium [Moles/volume] in Serum or Plasma

545

3583

1.66

22.39

3.1

2.9

mmol/l

0.8

0.08

502

3283

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

670

4644

1.60

22.19

4.5

4.1

ng/l

324.5

325.7

0.00

592

3993

(3019550) Sodium [Moles/volume] in Serum or Plasma

2266

20572

1.81

21.74

26.8

20.6

mmol/l

139.3

139.5

5.50

2210

19990

(3023103) Potassium [Moles/volume] in Serum or Plasma

2269

20613

1.81

21.65

27.1

20.7

mmol/l

4.0

1.42

2211

20000

(3024561) Albumin [Mass/volume] in Serum or Plasma

1242

9879

1.49

21.64

5.2

4.6

g/l

34.1

34.6

2.59

1145

9081

(3013115) Eosinophils [#/volume] in Blood

1282

10264

1.49

21.62

7.1

5.7

e9/l

0.2

0.14

1105

8808

(3037467) Urinalysis macro (dipstick) panel - Urine

1699

14422

1.52

21.40

5.7

4.9

—

(3006315) Basophils [#/volume] in Blood

1246

9940

1.49

21.25

6.8

5.5

e9/l

0.0

0.12

1043

8419

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

246

1294

2.00

21.15

5.2

6.7

mmol/l

24.7

25.0

0.50

241

1283

(3013650) Neutrophils [#/volume] in Blood by Automated count

1419

11638

1.48

20.94

10.1

8.7

e9/l

4.5

4.3

3.31

1221

10023

(3001604) Monocytes [#/volume] in Blood

1238

9901

1.48

20.62

6.8

5.5

e9/l

0.6

2.40

1035

8360

(3021601) Nitrite [Presence] in Urine by Test strip

1247

9999

1.48

20.43

6.1

5.7

estimate

0.0

0.00

307

1795

(3035350) Ketones [Presence] in Urine by Test strip

1244

9973

1.48

20.38

4.5

4.2

estimate

0.0

0.00

303

1798

(3004789) Transferrin [Mass/volume] in Serum or Plasma

511

3383

1.64

20.20

2.9

2.5

g/l

2.2

2.3

2.80

470

3093

(3022948) Iron [Moles/volume] in Serum or Plasma

542

3652

1.61

19.91

2.9

2.5

umol/l

11.3

12.1

1.99

500

3333

(3019198) Lymphocytes [#/volume] in Blood

1257

10137

1.47

19.74

6.9

5.6

e9/l

1.8

1.9

0.39

1088

8725

(3014111) Lactate [Moles/volume] in Serum or Plasma

345

2067

1.77

19.72

6.9

5.9

mmol/l

1.3

1.4

0.54

331

1978

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1367

11212

1.46

19.62

6.5

6.1

umol/l

11.9

12.1

0.30

1299

10593

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2249

20501

1.73

19.59

13.2

11.2

u/l

23.9

24.6

1.03

2148

19568

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

816

6049

1.51

19.51

2.4

2.3

mg/l

3.1

0.06

688

5097

(3009261) Glucose [Presence] in Urine by Test strip

1255

10137

1.46

19.44

4.5

4.2

estimate

0.0

0.19

298

1776

(3026008) Bacteria identified in Urine by Culture

994

7713

1.47

18.75

4.1

3.6

—

(40761511) CBC panel - Blood by Automated count

2192

19908

1.65

18.59

20.1

16.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

444

2900

1.64

18.36

1.9

1.8

—

(3007461) Platelets [#/volume] in Blood

2300

21184

1.76

18.17

32.6

25.4

e9/l

244.8

243.7

0.30

2213

20484

(3024731) MCV [Entitic volume]

2300

21185

1.76

18.16

32.5

25.3

91.9

91.6

2.45

2251

20736

(3035941) MCH [Entitic mass]

2300

21186

1.76

18.14

32.5

25.3

30.4

0.08

2252

20737

(3026361) Erythrocytes [#/volume] in Blood

2300

21187

1.76

18.12

32.6

25.4

e12/l

4.3

4.4

7.61

2190

20407

(3000963) Hemoglobin [Mass/volume] in Blood

2300

21191

1.76

18.06

32.9

25.5

g/l

129.6

131.9

10.50

2255

20750

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

441

2887

1.64

18.05

1.9

1.8

—

(3010813) Leukocytes [#/volume] in Blood

2300

21193

1.76

18.02

32.6

25.4

e9/l

7.1

6.9

1.74

2193

20413

(3042936) Bacteria identified in Isolate by Culture

466

3106

1.61

17.69

2.4

2.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2243

20551

1.68

17.66

26.3

20.4

umol/l

82.6

81.9

0.40

2243

20545

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

280

1630

1.80

17.56

1.7

—

(3012501) Base excess in Blood by calculation

121

517

2.41

17.49

4.6

4.7

mmol/l

2.5

2.7

0.53

367

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

635

4590

1.51

16.68

3.6

3.0

mmol/l

2.5

0.59

542

4005

(3010421) pH of Blood

132

608

2.23

16.05

4.6

4.4

7.4

0.20

117

507

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

292

1766

1.74

16.01

1.7

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

321

1996

1.69

15.91

3.2

2.3

u/l

43.7

59.7

0.26

264

1687

(3018677) aPTT in Platelet poor plasma by Coagulation assay

511

3562

1.54

15.80

1.9

2.0

30.0

0.05

499

3435

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

797

6097

1.44

15.48

3.1

u/l

36.3

35.2

0.12

735

5756

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

577

4149

1.50

15.37

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1983

17853

1.47

14.95

5.3

5.0

mu/l

2.0

2.1

0.69

1749

15955

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1180

9733

1.39

14.68

2.3

2.1

pmol/l

91.9

93.6

0.61

564

4935

(3015377) Calcium [Moles/volume] in Serum or Plasma

974

7785

1.40

14.58

3.7

3.3

mmol/l

2.4

0.44

845

6608

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1069

8689

1.39

14.45

2.5

2.2

nmol/l

78.1

79.8

1.20

920

7579

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1018

8222

1.39

14.23

3.3

2.8

ug/l

161.9

146.5

0.60

899

7413

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

131

635

2.12

14.04

2.0

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1706

15021

1.40

13.94

4.8

4.2

mm/h

15.9

14.7

2.05

1552

13668

(3028271) Lactate [Moles/volume] in Capillary blood

389

2.41

13.66

1.9

mmol/l

1.8

1.7

0.52

379

(40767503) Oxygen content in Capillary blood by calculation

109

500

2.23

13.43

2.3

2.5

15.8

15.9

0.07

262

(1616796) Gas panel - Central venous blood

111

519

2.19

13.05

3.1

3.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

742

5752

1.41

12.93

1.7

1.6

nmol/l

19.2

20.3

1.21

628

4828

(3003694) ABO and Rh group [Type] in Blood

638

4824

1.43

12.78

1.4

1.3

—

(3000991) Gas panel - Venous blood

299

1938

1.61

12.49

9.2

7.1

—

(3037522) Nuclear Ab [Titer] in Serum

343

2297

1.57

12.48

1.4

1.3

titre

569.7

554.1

0.06

531

(3011397) Hemoglobin [Presence] in Urine by Test strip

652

4967

1.42

12.48

4.0

4.1

—

(3052851) Hemolysis interference index of Serum or Plasma

139

721

1.98

12.42

4.1

3.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

193

1115

1.79

12.36

4.2

3.4

mmol/l

24.1

24.2

0.09

184

1004

(40768804) Tissue Pathology biopsy report

979

8026

1.35

11.83

2.3

2.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1137

9536

1.34

11.80

2.7

2.4

—

(3015736) pH of Urine

960

7859

1.35

11.67

3.8

3.9

—

6.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

827

6641

1.36

11.31

3.1

2.5

u/l

63.8

58.0

0.50

755

6065

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.79

11.11

7.5

4.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

229

1430

1.66

11.08

1.6

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

205

1246

1.70

10.99

8.9

8.0

mmol/l

24.0

24.4

0.97

190

1151

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

854

6922

1.35

10.90

2.2

u/l

189.2

213.3

0.47

791

6448

(3003458) Phosphate [Moles/volume] in Serum or Plasma

421

3031

1.46

10.78

6.7

5.0

mmol/l

1.0

0.12

385

2769

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1143

9691

1.32

10.62

4.5

4.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

339

2344

1.51

10.59

2.9

2.5

umol/l

9.0

9.8

0.22

292

2037

(3002256) Pathology report gross observation

376

2660

1.48

10.51

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1656

14814

1.33

10.35

4.3

4.1

pmol/l

15.2

15.1

0.38

1459

13147

(3014148) Varicella zoster virus Ab [Titer] in Serum

118

3.25

10.13

1.2

1.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

924

7648

1.32

10.02

3.1

3.2

ng/l

2009.8

1861.8

0.35

795

6625

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

139

777

1.83

9.95

2.1

1.8

u/l

38.5

39.1

0.10

124

660

(3025159) Blasts/100 leukocytes in Blood

235

1520

1.60

9.87

3.9

4.2

0.0

0.4

0.85

418

(3041096) Erythrocytes [Presence] in Urine by Automated

647

5096

1.36

9.77

4.5

4.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1983

18294

1.36

9.56

7.4

6.4

mmol/mol

42.1

40.8

5.54

1766

16559

(3021440) Promyelocytes/100 leukocytes in Blood

246

1636

1.56

9.17

4.1

0.3

0.1

0.78

491

(4035726)

277

1892

1.52

9.14

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

282

1936

1.51

9.08

1.7

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2049

19043

1.36

9.08

5.1

5.0

mmol/l

6.1

1.39

1776

16911

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

143

2.90

9.01

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

929

1.71

8.77

1.7

2.5

g/l

10.0

10.3

0.33

125

764

(3044640) Blood type and Crossmatch panel - Blood

834

6912

1.30

8.66

2.7

2.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

987

1.68

8.63

1.7

2.5

g/l

4.0

3.8

0.89

117

688

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

989

1.68

8.57

1.7

2.5

—

(3017181) Myelocytes/100 leukocytes in Blood

255

1735

1.52

8.56

4.1

1.4

0.8

0.87

539

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

990

1.68

8.54

1.7

2.5

g/l

7.7

7.5

0.80

118

715

(3007164) IgA [Mass/volume] in Serum or Plasma

434

3271

1.39

8.49

1.5

g/l

2.6

2.7

0.15

219

1854

(3021447) Carbon dioxide [Partial pressure] in Venous blood

322

2301

1.46

8.48

4.1

3.3

kpa

5.8

0.16

311

2237

(3020779) Urea [Moles/volume] in Serum or Plasma

299

2107

1.47

8.46

8.3

6.0

mmol/l

11.5

11.0

0.51

284

1978

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

109

595

1.87

8.45

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

109

595

1.87

8.45

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

179

2743

0.63

8.32

4.9

4.8

32.8

33.5

0.34

110

1768

(3002032) Base excess in Venous blood by calculation

319

2286

1.45

8.27

4.1

3.3

mmol/l

1.6

2.1

1.28

268

1844

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2059

19233

1.34

8.19

5.4

5.2

mmol/l

2.6

1.60

1794

17270

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

350

2.12

8.18

6.8

5.1

iu/ml

1734.9

814.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

146

2.77

8.13

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

491

3802

1.36

8.10

3.4

3.3

ug/l

0.8

0.14

356

2670

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

146

882

1.69

8.05

3.3

3.0

u/ml

1994.5

2691.1

0.13

124

751

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

490

1.93

8.04

3.2

3.0

mg/l

1.8

1.7

0.59

434

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1310

11565

1.27

8.04

3.2

u/l

54.2

54.7

0.06

1185

10485

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

150

917

1.67

7.91

1.8

2.6

g/l

3.2

0.08

118

704

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

484

1.91

7.67

1.8

1.9

mg/l

10.7

12.4

1.28

441

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

131

779

1.72

7.66

1.8

2.4

g/l

36.6

37.1

0.49

108

647

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

124

727

1.74

7.63

1.9

2.5

g/l

0.0

0.01

109

655

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

117

677

1.76

7.54

1.9

2.5

g/l

0.0

0.00

104

616

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

367

2744

1.39

7.48

3.2

3.9

u/l

244.3

251.2

0.45

342

2570

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

118

686

1.75

7.48

1.9

2.5

g/l

0.0

0.50

104

617

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

303

2.14

7.44

1.8

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

286

2052

1.44

7.36

2.1

2.7

g/l

66.0

66.1

0.07

250

1829

(3025941) Bacteria identified in Stool by Culture

158

1000

1.62

7.29

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

531

1.84

7.19

1.9

2.3

g/l

3.8

3.6

0.51

496

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

268

2.19

7.17

1.7

1.3

u/ml

112.2

125.8

0.39

(40768446) Kidney Pathology biopsy report

3.94

7.16

2.0

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

626

5101

1.30

7.14

1.9

1.8

nmol/l

1175.9

1168.5

0.07

475

3767

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

348

2600

1.39

7.12

3.8

ug/l

19.8

23.2

0.14

295

2136

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1026

8888

1.26

7.10

4.6

4.2

ng/l

101.1

112.3

0.06

780

6798

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

623

5086

1.30

6.99

1.7

1.6

mmol/l

1.4

1.3

0.38

473

4223

(40768797) Stomach Pathology biopsy report

370

2803

1.37

6.95

1.2

—

(3021788) Differential panel - Synovial fluid

401

1.95

6.94

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.71

6.91

1.2

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

524

1.82

6.88

2.6

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

542

4361

1.31

6.76

1.6

mg/l

1.9

1.5

1.18

418

3396

(3036481) Cortisol [Moles/volume] in Serum or Plasma

251

1787

1.45

6.73

2.0

2.1

nmol/l

369.9

382.4

0.44

231

1610

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

135

839

1.64

6.72

1.9

2.6

g/l

0.7

1.2

0.86

110

709

(3000494) Fungus identified in Specimen by Culture

308

2280

1.40

6.64

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

386

2965

1.35

6.63

1.3

iu/ml

31.5

39.2

0.55

123

904

(3002179) Metamyelocytes/100 leukocytes in Blood

224

1565

1.47

6.62

3.9

0.8

0.6

0.50

376

(3024980) IgG subclass 4 [Mass/volume] in Serum

259

2.15

6.52

1.6

g/l

0.7

0.9

0.52

195

(3000570) Elastase.pancreatic [Mass/mass] in Stool

108

639

1.72

6.48

1.4

1.5

ug/g

247.5

274.7

0.69

379

(3042733) HLA Ab [Presence] in Serum

4.57

6.45

4.8

4.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

385

2968

1.35

6.45

8.0

6.1

mmol/l

104.3

104.1

0.19

379

2888

(3017143) Hepatitis C virus Ab [Presence] in Serum

223

1568

1.46

6.39

1.8

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

237

1688

1.44

6.35

1.8

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

245

1756

1.44

6.34

1.8

2.5

—

(3022145) Colonoscopy Study observation

289

2136

1.40

6.29

1.2

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

381

2945

1.34

6.27

2.4

1.8

0.15

334

2565

(3014007) Fractional oxyhemoglobin in Arterial blood

210

1467

1.47

6.22

9.9

7.9

94.0

93.6

0.54

210

1460

(3024354) Oxygen [Partial pressure] in Venous blood

263

1916

1.41

6.22

3.3

2.8

kpa

4.7

4.5

0.67

253

1855

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

259

1885

1.42

6.16

4.2

3.6

ng/l

98.3

95.5

0.17

212

1577

(3022217) INR in Platelet poor plasma by Coagulation assay

453

3600

1.31

6.14

26.3

29.8

inr

1.3

1.5

0.84

485

(3021879) Hepatitis B virus core Ab [Presence] in Serum

150

982

1.56

6.05

1.5

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

152

2.45

6.03

1.5

1.3

g/l

6.7

7.2

0.28

105

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

460

3674

1.31

6.00

1.3

1.2

u/ml

1.5

1.7

0.07

904

(3026493) Urate [Moles/volume] in Serum or Plasma

659

5508

1.26

6.00

2.8

umol/l

2779.1

7452.8

2.81

521

4624

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

284

2112

1.39

5.96

2.5

2.1

g/l

0.2

0.05

262

1950

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

154

1025

1.53

5.78

2.7

3.2

pmol/l

4.2

4.4

1.08

133

884

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

400

1.85

5.71

3.8

3.4

58.9

59.1

0.05

400

(40768443) Skin Pathology biopsy report

141

923

1.56

5.70

1.3

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

477

3853

1.29

5.70

4.9

4.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.81

5.56

1.5

1.4

1.9

2.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

152

2.39

5.55

1.6

1.3

g/l

0.3

0.4

2.01

104

(3028192) IgG subclass 2 [Mass/volume] in Serum

152

2.39

5.55

1.6

1.3

g/l

2.5

2.8

0.38

106

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

122

2.56

5.54

1.1

1.2

—

(3003396) Base excess in Arterial blood by calculation

357

2783

1.33

5.52

7.3

6.5

mmol/l

0.6

1.2

2.20

280

2155

(3003338) MCHC [Mass/volume]

1679

15576

1.22

5.41

30.4

23.0

g/l

330.1

330.8

2.34

1656

15385

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

148

2.38

5.39

1.4

1.2

titre

95.0

171.0

—

(3008898) HLA-B27 [Presence]

408

1.81

5.38

1.1

1.0

—

(3011985) Renin [Units/volume] in Plasma

239

2.07

5.37

1.2

1.3

mu/l

104.6

50.1

0.75

206

(4062490)

155

2.34

5.33

1.6

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

866

7540

1.22

5.31

4.9

4.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

123

794

1.58

5.31

1.8

3.3

ratio

1.6

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1976

18662

1.25

5.29

4.7

4.6

mmol/l

4.4

4.5

1.82

1770

16834

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

138

2.41

5.21

1.2

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

125

815

1.56

5.17

1.8

3.3

mg/l

34.1

75.1

1.64

678

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

504

1.71

5.13

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

640

5415

1.24

5.13

4.9

4.6

estimate

0.0

0.69

287

1724

(3030905) Polymorphonuclear cells [#/volume] in Blood

385

1.81

5.13

3.6

3.1

e9/l

4.6

4.3

0.32

385

(3034860) Kappa light chains.free [Mass/volume] in Serum

125

818

1.55

5.10

1.8

3.3

mg/l

47.6

131.3

0.66

678

(3019225) pH of Specimen

174

2432

0.69

5.09

5.7

4.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

135

899

1.53

5.09

3.0

2.6

u/ml

0.3

0.4

2.36

529

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

307

2370

1.33

5.08

2.8

3.1

ng/l

251.2

243.8

0.12

280

2163

(3051611) Lipemic interference index of Serum or Plasma

265

1.98

5.08

4.1

3.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.09

5.06

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

103

646

1.62

5.03

1.2

u/ml

0.6

0.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

354

2794

1.31

5.01

7.4

6.4

kpa

12.2

11.9

0.60

337

2644

(3011648) Oxygen content in Venous blood

166

2.25

5.01

1.8

1.6

11.5

10.7

0.55

166

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.70

5.00

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.70

5.00

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

354

2795

1.31

5.00

7.4

6.4

kpa

5.0

5.1

0.33

336

2641

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

224

1650

1.39

4.99

3.9

2.9

ml/min/173m2

53.3

59.6

1.32

743

(3051651) Icteric interference index of Serum or Plasma

136

2.37

4.90

4.5

3.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

130

2.40

4.89

2.3

2.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

506

1.68

4.81

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

172

1218

1.44

4.80

1.5

1.7

g/l

1.7

1.5

1.28

145

1041

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.01

4.77

9.7

14.7

mmol/l

4.7

5.5

—

(3024928) Oxygen saturation in Venous blood

485

1.69

4.74

3.3

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

211

2820

0.73

4.74

11.2

8.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

408

1.74

4.53

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.87

4.49

4.3

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

143

2.25

4.40

1.0

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

621

5317

1.22

4.36

2.7

2.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

266

1.90

4.36

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

506

1.64

4.32

1.7

2.1

90.0

88.0

0.29

479

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1945

18465

1.21

4.30

4.7

4.6

mmol/l

1.4

1.5

1.33

1691

16538

(3023420) DNA double strand Ab [Units/volume] in Serum

171

2.12

4.28

1.1

1.3

—

31.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

516

1.63

4.25

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

176

1284

1.40

4.19

3.6

3.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

256

1.89

4.17

1.1

—

(3036603) Volume of Urine

115

2.36

4.15

2.2

1.3

2021.1

1647.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

374

1.73

4.13

1.2

u/ml

3.3

5.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

352

2847

1.27

4.12

1.3

1.2

u/ml

21.1

14.9

0.57

115

994

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.81

4.12

1.1

1.2

ratio

1.1

—

(3016502) Oxygen saturation in Arterial blood

310

2469

1.29

4.10

7.8

6.8

95.2

95.3

0.05

301

2366

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.36

4.08

1.2

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

223

1.94

4.06

1.4

1.3

pmol/l

345.2

272.7

0.55

161

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

8.02

4.06

1.5

2.8

—

(3036489) Thrombin time

103

683

1.53

4.02

1.7

1.9

24.0

21.9

0.60

622

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

117

2.32

4.01

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

117

2.32

4.01

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

117

2.32

4.01

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

363

1.73

3.99

4.3

2.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

551

1.58

3.92

1.3

—

15.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.43

3.90

1.1

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

458

1.63

3.88

1.2

u/ml

4.9

7.9

0.43

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

237

1.87

3.74

1.4

1.6

—

(3004775) Volume in Urine collected for unspecified duration

174

2.02

3.74

2.9

2.1

631.6

637.9

0.03

101

(40759836) Histone Ab [Presence] in Serum by Immunoblot

116

2.25

3.64

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

116

2.25

3.64

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

116

2.25

3.64

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.95

3.57

1.1

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

501

1.57

3.55

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

136

981

1.41

3.50

4.9

3.9

u/ml

51.0

80.6

1.53

129

943

(1761868) Lipid panel - Serum or Plasma

608

5298

1.19

3.47

3.4

3.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

602

1.51

3.43

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

450

1.59

3.43

1.2

u/ml

6.7

4.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

628

1.50

3.39

2.8

3.4

mmol/l

23.5

25.0

2.56

543

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.25

3.34

1.3

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

186

1423

1.33

3.33

2.4

2.8

g/l

10.3

10.6

0.33

164

1285

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

257

2057

1.28

3.30

1.4

—

(4281824)

241

1.80

3.27

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

609

1.49

3.26

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

112

792

1.43

3.24

1.6

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

165

1246

1.35

3.23

9.2

9.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

575

5017

1.19

3.21

1.9

1.7

pmol/l

35294558.8

19119899.8

0.32

442

4043

(3024471) HLA-A [Type]

3.17

3.21

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

612

1.49

3.19

1.3

1.2

—

(3000492) Spirometry study

200

1558

1.31

3.16

1.7

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

747

6669

1.17

3.16

5.5

5.4

ug/l

3.4

4.5

0.73

630

5893

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

382

1.61

3.12

5.5

1.4

nmol/l

0.8

0.36

310

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

534

1.51

3.11

1.9

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

253

1.75

3.09

1.5

56.8

63.2

0.39

163

(3028626) Oxygen [Partial pressure] in Capillary blood

568

1.49

3.07

2.2

3.1

kpa

8.0

7.9

0.24

524

(3023183) Ammonium ion [Moles/volume] in Plasma

479

1.54

3.07

2.1

2.4

umol/l

33.5

32.3

0.21

391

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

181

1.89

3.05

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

119

2.11

3.04

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

119

2.11

3.04

1.3

1.5

—

(3045414) Leukocytes [Presence] in Urine

129

954

1.37

2.92

2.3

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

239

1928

1.26

2.90

1.9

2.1

ug/g

139.1

144.7

0.06

188

1492

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.59

2.87

2.8

2.2

mmol/l

7.0

7.7

—

(3044941) Cell count panel - Synovial fluid

375

1.59

2.87

1.5

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

561

1.48

2.86

1.9

2.2

g/l

125.4

127.3

0.25

403

(3024932) HLA-DR beta [Type]

3.06

2.80

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.65

2.79

1.1

1.0

miu/ml

2362.8

1657.2

1.30

(3009508) Creatinine [Moles/volume] in Urine

739

6648

1.16

2.78

3.6

3.1

mmol/l

6.4

6.9

3.34

584

5474

(4306422)

173

1.86

2.77

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

159

1.90

2.75

1.5

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

550

0.56

2.73

1.4

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.22

2.67

1.4

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1860

17833

1.15

2.67

4.2

4.1

mmol/l

1.3

0.40

1592

15807

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

1.94

2.65

1.3

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.13

2.64

1.1

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

472

1.50

2.64

1.4

1.2

titre

73.3

88.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

189

1501

1.28

2.62

3.3

2.9

g/l

125.2

126.8

0.45

184

1466

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

603

5364

1.16

2.62

4.5

4.7

22.4

21.9

0.31

299

2788

(3012516) Albumin [Mass/volume] in Urine

724

6528

1.15

2.62

3.6

3.2

mg/l

408.8

347.3

0.14

476

4109

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

847

0.65

2.59

1.6

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

268

1.65

2.56

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

268

1.65

2.56

3.6

3.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

200

1.76

2.56

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

7.15

2.55

9.8

9.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.14

2.54

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

136

1038

1.33

2.54

1.9

ug/l

2.8

2.4

0.13

117

887

(3025315) Body weight

5.46

2.54

5.3

4.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

379

1.54

2.54

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

129

1.95

2.50

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

196

1575

1.26

2.49

1.6

1.7

1.6

0.69

159

1321

(3003181) Sodium [Moles/volume] in Urine

479

1.47

2.48

1.3

mmol/l

57.9

62.2

0.52

381

(3003434) Protein [Mass/volume] in Pleural fluid

359

1.54

2.43

1.5

g/l

31.7

30.6

0.23

330

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

590

1.42

2.42

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

125

951

1.33

2.40

2.5

2.6

—

(40768800) Prostate Pathology biopsy report

433

1.49

2.40

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

212

1.71

2.39

1.1

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.64

2.36

1.4

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.64

2.36

1.4

1.2

85.1

96.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

147

1148

1.30

2.35

1.9

1.8

g/l

1.2

1.5

1.69

137

1022

(3017446) Testosterone [Moles/volume] in Serum or Plasma

142

1107

1.30

2.31

2.2

2.1

nmol/l

11.1

12.1

0.68

120

948

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.86

2.30

1.1

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

266

2233

1.21

2.28

2.5

2.4

e9/l

72.0

69.0

0.53

184

1693

(3016330) Potassium [Moles/time] in 24 hour Urine

4.62

2.27

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

756

6898

1.14

2.25

4.7

3.9

mg/mmol

18.7

8.8

2.50

464

4290

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.05

2.21

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.05

2.21

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

110

833

1.33

2.21

1.8

2.1

ug/l

233.7

524.8

2.30

103

784

(3038177) Helicobacter pylori Ab [Presence] in Serum

210

1.68

2.20

1.4

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

265

1.59

2.17

1.4

1.2

u/ml

305.4

301.4

0.03

152

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

347

1.51

2.12

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

615

1.38

2.10

1.7

1.6

—

(36660697) Celiac disease serology panel - Serum

167

1347

1.26

2.09

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.26

2.07

1.0

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

124

1.86

2.06

2.8

3.9

—

(3012441) Differential panel - Pleural fluid

285

1.55

2.06

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

457

1.43

2.05

1.4

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

326

1.51

2.04

1.1

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

302

1.53

2.03

1.6

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

286

1.55

2.03

1.4

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

223

1.62

2.02

1.3

1.2

u/l

75.1

55.1

0.61

148

(3008295) Osmolality of Serum or Plasma

223

1.62

2.02

1.3

mosm/kgh2o

281.4

274.6

1.29

154

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.41

2.02

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

200

1.66

2.02

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.64

2.01

1.7

1.1

—

(3004451) EKG impression Narrative

111

1.90

2.00

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

279

1.55

2.00

1.5

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

170

1.71

2.00

1.6

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

410

1.45

1.99

1.7

1.8

iu/l

2.2

4.7

2.56

135

(40760888) Immunoglobulin light chains.free panel - Serum

613

1.37

1.99

1.9

3.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

521

1.39

1.95

1.4

1.6

iu/ml

3.7

1.3

0.31

123

(3045788) Cell count panel - Pleural fluid

265

1.56

1.95

1.6

1.5

—

(3021901) Oxygen saturation in Capillary blood

479

1.41

1.95

2.4

2.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

712

1.33

1.92

3.7

3.3

nmol/l

0.8

0.31

537

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.25

1.90

1.3

1.1

u/ml

—

14.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

373

1.46

1.89

1.5

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

103

793

1.31

1.89

1.3

—

(3042631) Mycobacterium sp identified in Specimen

325

1.49

1.86

2.2

2.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.03

1.85

1.3

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.03

1.85

1.2

g/l

—

0.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

105

814

1.30

1.84

2.3

2.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

152

1.72

1.83

1.8

1.9

u/l

532.6

2997.7

—

(3044290) Cell count panel - Cerebral spinal fluid

344

1.46

1.80

1.5

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

199

1.62

1.80

1.6

1.4

23.7

28.8

0.32

128

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.01

1.79

1.3

1.2

—

(3022621) pH of Urine by Test strip

183

1520

1.22

1.79

3.9

3.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

297

0.54

1.74

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.92

1.72

1.4

1.6

—

(3000012) Reticulocyte production index

118

1.79

1.70

1.3

1.5

—

(3037756) Immunofixation for Serum or Plasma

570

1.34

1.69

1.2

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

114

905

1.27

1.68

1.4

1.2

u/ml

228.4

180.3

0.29

105

825

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

104

1.83

1.67

1.7

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.16

1.66

1.2

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

385

1.41

1.64

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

173

1.62

1.64

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.25

1.63

1.0

1.1

umol/24h

0.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

637

1.31

1.60

1.6

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.07

1.59

1.8

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

312

1.45

1.59

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

280

1.47

1.57

1.5

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

122

1.73

1.54

1.2

1.5

promille

1.5

1.1

0.55

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

184

1.58

1.54

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

520

1.34

1.52

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

366

1.40

1.51

1.4

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.86

1.50

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.86

1.50

1.2

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.90

1.49

1.9

2.4

u/ml

848.7

1387.4

0.83

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.44

1.48

1.2

1.1

—

(1002224) Polysomnography panel

464

1.34

1.44

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.31

1.43

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

229

1.49

1.41

1.3

nmol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

492

1.33

1.41

1.6

—

(21494755) Public health laboratory ask at order entry panel

724

0.74

1.40

1.3

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.42

1.39

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.90

1.39

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.94

1.38

1.5

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

198

1.52

1.37

1.1

1.2

u/ml

3.9

3.8

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.61

1.36

2.3

1.8

68.5

49.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.94

1.36

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

401

1.35

1.34

1.1

1.2

—

64.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.78

1.33

2.1

1.4

g/l

1.0

0.06

(3028308) Erythrocytes [#/volume] in Pleural fluid

300

1.41

1.31

1.5

1.4

e6/l

80837.4

41493.4

0.25

175

(3013512) EKG study

712

6655

1.10

1.30

4.6

4.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

193

1.51

1.29

1.7

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.05

1.26

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

107

1.69

1.25

1.3

1.2

mmol/l

11.9

11.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

107

1.69

1.25

1.1

mg/l

49.6

41.9

0.21

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.82

1.25

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

278

0.61

1.24

4.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

262

1.42

1.22

1.2

miu/ml

204.6

192.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

221

1.45

1.21

1.3

1.5

—

(3023410) Appearance of Cerebral spinal fluid

172

1.52

1.20

1.6

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

177

1531

1.17

1.18

3.7

kpa

5.0

5.2

1.24

160

1398

(3006576) Bicarbonate [Moles/volume] in Blood

1.88

1.18

9.5

6.0

mmol/l

23.9

24.8

0.42

(3019977) pH of Arterial blood

133

1.58

1.17

2.2

2.8

7.4

0.01

(3033799) Differential panel - Peritoneal fluid

1.78

1.16

1.6

2.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.50

1.15

2.6

1.6

8.2

12.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.15

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

1.15

0.0

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

292

1.38

1.13

1.9

1.5

mu/l

461.7

292.0

1.01

260

(3023199) Leukocytes [#/volume] in Pleural fluid

335

1.35

1.13

1.5

1.4

e6/l

1183.1

1935.8

0.84

236

(3024522) Salmonella sp identified in Specimen by Organism specific culture

295

0.64

1.13

1.6

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.34

1.12

1.4

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

294

0.64

1.12

1.6

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.82

1.09

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

551

1.26

1.06

1.6

e6/l

12041.8

16142.5

0.66

397

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

153

1.51

1.06

1.7

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.12

1.05

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

392

1.31

1.05

1.2

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

146

1258

1.17

1.05

1.2

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.27

1.03

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

289

1.35

1.03

1.3

1.1

—

(3017704) Immunofixation for Urine

146

1.51

1.03

1.2

1.6

—

(3006270) Folate [Moles/volume] in Blood

204

1.43

1.03

1.1

1.2

nmol/l

377.2

339.2

0.36

166

(44816559) Phosphatidylethanol [Mass/volume] in Blood

272

1.37

1.02

1.1

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

188

1.44

1.01

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.89

1.01

1.1

1.2

g/l

0.4

0.3

—

(3011412) CD3 cells [#/volume] in Blood

155

1.49

1.01

1.7

1.9

e9/l

1.1

1.0

0.06

(3001019) Free T4 and TSH panel - Serum or Plasma

449

0.73

1.00

1.6

1.7

—

(3028433) Virus identified in Specimen by Culture

1.77

1.00

1.5

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.88

1.00

2.2

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

297

0.67

0.99

1.6

1.4

—

(40768806) Pleura Pathology biopsy report

283

1.35

0.98

1.7

1.6

—

(3009343) pH of Capillary blood

172

1510

1.15

0.98

3.8

3.7

7.4

0.05

186

(3005988) Vibrio sp identified in Specimen by Organism specific culture

295

0.68

0.96

1.6

1.4

—

(3017569) Oxygen content in Arterial blood

124

1.54

0.96

1.8

2.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.80

0.96

1.7

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

456

0.74

0.95

1.5

1.7

mg/l

2.3

4.1

0.74

348

(3025468) Yersinia sp identified in Specimen by Organism specific culture

294

0.68

0.95

1.6

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.65

0.94

2.1

2.2

umol/l

79.8

50.3

1.56

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.89

0.94

1.3

1.4

ng/l

80.0

101.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

293

0.68

0.94

1.6

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

798

1.20

0.94

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

391

1.28

0.93

1.6

1.3

e6/l

68.1

32.1

0.23

306

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

183

1.42

0.93

1.3

u/l

26.1

10.1

0.74

170

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

234

1.37

0.93

1.3

—

(3023419) Bacteria identified in Sputum by Culture

312

1.32

0.93

2.3

2.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

392

1.28

0.92

1.6

1.4

e6/l

1465.2

609.3

0.30

322

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

244

1.36

0.90

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

202

1.39

0.89

1.0

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

135

1.48

0.89

1.5

1.1

—

(3025130) Human papilloma virus identified in Specimen

119

1.52

0.88

1.2

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.61

0.87

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.86

0.87

1.3

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.00

0.87

1.0

1.2

—

(4024509)

251

0.68

0.85

1.9

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

112

1.52

0.84

1.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

1.52

0.84

1.5

1.9

e6/l

663.4

634.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1048

0.84

1.9

2.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.94

0.84

1.0

1.3

nmol/l

8.1

5.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

542

1.22

0.84

3.1

2.3

ug/min

134.5

74.8

0.43

308

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

146

1285

1.14

0.83

2.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

251

2285

1.11

0.83

2.4

2.5

ug/l

5.8

6.6

0.53

198

1927

(3037121) Protein [Mass/volume] in Urine

820

1.18

0.81

3.5

2.9

g/l

0.4

0.3

1.05

294

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

138

1.45

0.81

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

364

1.27

0.81

2.8

2.4

—

(3000285) Sodium [Moles/volume] in Blood

1.70

0.80

1.3

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

1.51

0.78

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

123

1.47

0.77

2.2

2.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.77

0.76

1.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.77

0.76

1.5

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.76

0.0

7.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.52

0.75

1.1

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.70

0.75

1.1

1.2

117.3

112.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.60

0.74

2.6

2.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.80

0.72

1.3

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

362

1.25

0.71

1.2

1.3

—

(4212803)

1.92

0.70

1.0

1.1

—

(3024263) Appearance of Synovial fluid

126

1.43

0.70

1.6

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

195

1.34

0.69

1.2

u/ml

3.7

4.9

—

100

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.85

0.68

1.4

1.5

umol/l

39.6

44.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.67

0.68

1.3

1.0

—

(4010399)

130

1458

0.89

0.67

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

162

1460

1.12

0.67

3.9

3.6

mmol/l

1.4

2.0

0.87

107

1069

(3014891) Appearance of Pleural fluid

1.63

0.66

1.0

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

179

1.34

0.66

4.1

3.2

mg/l

128.0

21.3

1.01

141

(44806420)

0.53

0.66

1.4

2.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.79

0.66

1.0

1.2

umol/24h

1.6

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.79

0.66

1.6

2.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.79

0.66

1.2

u/l

11.0

23.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.57

0.65

1.8

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.57

0.65

1.8

2.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.61

0.65

1.5

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

215

1.31

0.65

2.0

2.3

u/field

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

120

1.42

0.64

1.7

1.8

16.3

14.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

966

0.87

0.64

1.8

—

(3035880) pH of Pleural fluid

155

1.36

0.63

1.4

1.3

—

(4027681)

1.52

0.62

1.3

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

288

1.25

0.62

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.63

0.62

1.4

2.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

114

1.41

0.58

1.4

1.3

u/ml

0.0

1.3

—

(3020650) Glucose [Presence] in Urine

1.51

0.58

1.0

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

175

1.32

0.58

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

282

1.24

0.58

1.2

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

123

1.38

0.57

1.8

68.8

70.8

0.17

112

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.48

0.57

1.4

1.5

g/l

26.9

25.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.51

0.56

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.46

0.56

2.0

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

150

1.34

0.55

1.4

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.62

0.55

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.62

0.55

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

257

1.25

0.55

1.3

—

(4094501)

505

1.17

0.54

1.1

—

(3034426) Prothrombin time (PT)

1.58

0.54

1.0

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

294

1.23

0.54

13.4

6.3

mmol/l

8.3

7.5

0.44

248

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.54

0.53

1.2

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.62

0.52

1.8

1.7

—

(4034850)

648

0.86

0.50

12.3

12.7

—

(3017732) Neutrophils [#/volume] in Blood

142

1298

1.10

0.49

2.7

3.2

e9/l

4.6

4.1

0.65

922

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.49

0.49

1.2

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

223

0.76

0.48

1.0

—

(4211845)

110

0.64

0.48

3.7

3.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

401

1.18

0.47

3.7

1.0

1.3

0.55

303

(3039443) Prostate specific Ag panel - Serum or Plasma

255

0.78

0.47

1.7

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.43

0.45

1.2

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

220

0.77

0.45

1.5

1.2

e6/l

12175.6

106456.6

—

146

(40761535) Cells panel - Urine sediment

206

1927

1.07

0.44

3.8

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

128

0.70

0.43

1.0

mg/l

317.2

293.2

—

112

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.61

0.43

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

805

0.89

0.41

1.2

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.41

0.0

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.36

0.41

1.9

2.0

32.6

28.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.40

0.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.40

0.0

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

(4133840)

1.47

0.40

1.2

1.1

—

(40768441) Liver Pathology biopsy report

132

1.29

0.40

1.7

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

101

0.69

0.39

1.3

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.31

0.39

2.0

4.6

9.8

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

187

1.23

0.39

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

289

1.18

0.38

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.33

0.37

1.5

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

112

0.71

0.37

1.4

2.8

—

(3044007) Cell count panel - Peritoneal fluid

1.31

0.37

1.3

2.0

—

(3019060) Gas panel - Arterial blood

176

1652

1.07

0.36

4.3

4.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

190

0.79

0.35

1.1

1.2

mmol/l

8.9

7.7

0.70

132

(3045424) Erythrocytes [Presence] in Urine

341

0.85

0.35

1.3

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

227

1.19

0.34

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

1.29

0.31

1.1

—

(3006462) Nitrate [Presence] in Urine

100

0.70

0.30

3.7

4.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.30

0.30

1.6

3.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

184

1.20

0.30

1.8

1.5

—

1696.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

932

0.92

0.30

4.8

3.9

mmol/l

24.1

24.9

1.22

847

(3052592) Norovirus Ag [Presence] in Stool

1.25

0.29

1.0

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

148

1.22

0.29

1.2

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

159

1.20

0.26

1.1

u/ml

0.3

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

142

1.20

0.24

1.0

u/ml

6.1

3.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.28

0.24

1.3

ug/l

37.2

401.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.74

0.24

1.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.74

0.24

1.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.74

0.24

1.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.74

0.24

1.0

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

303

1.12

0.23

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

148

1553

0.95

0.23

7.0

6.6

mmol/l

24.1

24.6

0.67

141

1444

(4268621)

134

1.20

0.22

2.5

2.3

—

(3006653) Thiamine [Moles/volume] in Blood

0.76

0.22

1.0

1.2

nmol/l

160.3

135.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.22

0.22

4.2

3.2

169.0

196.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

252

0.87

0.21

3.1

2.8

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.0

—

(3022313) Gas panel - Capillary blood

104

1099

0.94

0.21

4.3

3.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

209

0.86

0.21

1.6

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

104

0.77

0.21

1.3

1.4

nmol/l

0.7

1.1

—

(44813793)

104

0.77

0.21

1.0

—

(3020491) Glucose [Moles/volume] in Blood

154

1.17

0.21

2.2

3.1

mmol/l

8.6

7.0

0.88

102

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

2.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.5

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.5

—

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

230

1.13

0.20

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

145

1.17

0.20

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

224

2163

1.04

0.20

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

9.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.20

0.0

1.9

—

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.20

0.0

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

155

0.84

0.20

1.4

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

113

0.80

0.20

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

115

0.78

0.20

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.20

0.19

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.20

0.19

1.5

1.6

ug/l

9.9

9.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.20

0.19

1.3

1.1

106.7

102.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

510

0.92

0.19

4.0

3.9

mg/l

22.5

28.7

1.25

332

(3027273) Bicarbonate [Moles/volume] in Venous blood

131

1251

1.05

0.19

3.9

3.2

mmol/l

25.0

25.2

0.32

123

1219

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.18

0.19

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

146

1.17

0.19

1.1

—

(21494434) Karyotype in Bone marrow

222

1.13

0.19

1.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.13

0.18

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.13

0.18

2.5

2.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

744

0.94

0.18

5.7

3.8

mmol/l

3.9

0.14

688

(3038026) Centromere Ab [Units/volume] in Serum

166

1.15

0.18

1.3

1.1

—

49.9

—

(3005570) Glucose [Moles/volume] in Urine

237

0.88

0.17

2.2

2.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.13

0.17

1.1

1.8

ug/l

21.1

152.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

243

1.11

0.17

1.7

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.22

0.17

1.4

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.75

0.17

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

120

0.83

0.16

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

111

1.17

0.15

1.1

1.8

umol/l

3.8

14.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.79

0.15

1.0

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.14

0.15

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

169

1745

0.97

0.15

1.5

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.80

0.14

1.1

1.2

mmol/l

7.4

6.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

0.86

0.14

1.7

1.8

—

(3019150) Specific gravity of Urine by Refractometry

440

4475

0.98

0.14

4.9

4.8

kg/l

1.0

0.29

700

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

705

0.95

0.14

1.6

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

980

0.96

0.13

1.1

iu/ml

163.8

138.5

0.16

348

(3020876) Protein [Mass/time] in 24 hour Urine

189

1.11

0.13

1.6

1.9

—

1.0

—

(44806118)

228

1.10

0.13

1.9

1.5

—

(44790047)

228

1.10

0.13

1.9

1.5

—

(44790048)

228

1.10

0.13

1.9

1.5

—

(44790049)

228

1.10

0.13

1.9

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

159

0.88

0.13

3.1

1.4

—

(3028300) Cannabinoids [Presence] in Urine

221

0.90

0.12

1.2

2.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

488

0.94

0.12

1.5

1.4

—

(3014271) Vancomycin [Susceptibility]

179

0.89

0.12

4.6

3.1

—

(3027008) Opiates [Presence] in Urine

220

0.91

0.12

1.2

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

219

0.91

0.11

1.2

2.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

219

0.91

0.11

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

416

1.06

0.11

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

270

0.93

0.10

1.0

1.1

iu/ml

6.0

79.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

115

1.13

0.10

1.2

1.4

umol/l

12.3

15.0

1.03

104

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

397

1.06

0.10

1.2

mmol/l

3.9

0.06

370

(3047181) Lactate [Moles/volume] in Blood

738

0.96

0.10

4.1

6.3

mmol/l

1.3

0.06

651

(3008536) Aspergillus sp Ab [Presence] in Serum

1.11

0.09

1.2

1.6

—

(3022689) Creatine [Moles/volume] in Urine

1.06

0.09

1.4

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

174

1.09

0.09

1.1

1.0

u/ml

1.4

2.1

—

(3027944) Amphetamines [Presence] in Urine

217

0.92

0.09

1.2

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.05

0.08

1.3

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

136

1.10

0.08

1.5

u/l

2.6

7.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.03

0.08

1.3

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.81

0.08

1.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

0.86

0.07

1.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.86

0.07

1.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.86

0.07

1.0

1.5

—

(40765096) Chromosome analysis panel by Banding

0.82

0.07

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.83

0.07

1.1

1.6

—

(3016879) Cocaine [Presence] in Urine

204

0.93

0.07

1.2

2.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

122

0.90

0.07

1.5

2.0

—

28.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.87

0.06

1.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.87

0.06

1.0

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.85

0.06

1.0

1.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

640

1.03

0.06

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

629

0.97

0.06

1.5

1.7

—

(3020891) Body temperature

100

979

1.02

0.06

7.0

4.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

120

0.92

0.05

3.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

120

0.92

0.05

3.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

160

0.94

0.04

3.0

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

111

1.08

0.04

1.5

1.6

—

10.5

—

(3051593) INR in Capillary blood by Coagulation assay

141

1.06

0.03

22.5

15.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

151

1.06

0.03

2.8

4.9

u/ml

28.5

30.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

118

0.93

0.03

1.3

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

118

0.93

0.03

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

118

0.93

0.03

1.3

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

118

0.93

0.03

1.3

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

132

1.06

0.02

1.5

1.2

mmol/l

2.2

2.1

0.20

123

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

142

1.06

0.02

1.2

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

142

1.06

0.02

1.7

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

142

1.06

0.02

1.2

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

152

1.05

0.02

2.5

2.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

162

1.05

0.02

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

107

0.93

0.02

1.3

1.5

—

(3025577) Chromium [Mass/volume] in Blood

157

0.95

0.01

1.9

2.1

ug/l

3.8

1.7

0.63

131

(1001926) Buprenorphine [Presence] in Urine by Screen method

176

0.97

0.00

1.1

2.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

256

0.98

0.00

4.0

3.5

61.0

57.3

0.30

162

(3018405) Lactate [Moles/volume] in Arterial blood

884

1.01

0.00

4.9

3.6

mmol/l

1.3

1.4

1.20

868

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

1.03

0.00

1.1

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

139

1.01

0.00

1.0

u/ml

2.5

1.8

—

(4146454)

264

0.98

0.00

2.7

—

(40768793) Breast Pathology biopsy report

480

1.00

0.00

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

112

0.98

0.00

4.5

6.1

—

(3047189) Immunofixation for 24 hour Urine

108

1.02

0.00

1.8

1.6

—

(3011288) Drugs identified in Urine by Screen method

150

1.00

0.00

1.1

3.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

195

0.97

0.00

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

195

0.97

0.00

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

195

0.97

0.00

1.7

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

124

0.97

0.00

4.8

3.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

713

1.00

0.00

4.9

4.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

418

1.00

0.00

1.3

1.5

—

(40757373) Influenza virus identified in Isolate

0.97

0.00

1.3

1.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.00

0.00

1.2

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

4.3

—

10.7

—

(4015189)

0.95

0.00

3.2

1.8

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.91

0.00

6.8

3.1

13.7

13.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.94

0.00

1.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

2.7

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.3

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.0

4.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.94

0.00

1.0

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.2

—

4.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

4.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.91

0.00

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.4

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.0

—

28.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_GLAUCNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_GLAUCNAS	1.308 [1.16, 1.47]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.037

During the follow-up period (1.1.1998 — 31.12.2019), 3872 out of 10572 females with H7_GLAUCNAS died.

Males

Parameter	HR [95% CI]	p-value
H7_GLAUCNAS	1.303 [1.12, 1.52]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 2175 out of 6187 males with H7_GLAUCNAS died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCNAS.

N-year risk	Females	Males
1	0.136%	0.221%
5	0.748%	1.452%
10	1.749%	3.565%
15	3.474%	6.833%
20	5.94%	11.611%

Relationships between endpoints

↥

Index endpoint: H7_GLAUCNAS – Other and unspecified glaucoma

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other and unspecified glaucoma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints